CLINICAL ROLE -
New Drug Fortifies Efficacy of Common Cancer Drug
A combination of doxorubicin plus an aldose reductase inhibitor prevented cardiotoxicity in patients with colon cancer.
Read More
First Pharmaceutical Formulations of Cannabidiol in Development for Multiple Sclerosis
Potential treatment for primary progressive multiple sclerosis is an oral pill consisting of pharmaceutical formulations of purified THC and CBD.
Extra-Virgin Olive Oil Protects Against Alzheimer's Disease
A diet enriched with extra-virgin olive oil observed to reduce amyloid plaque and phosphorylated tau in mice.
Research Seeks to Weaponize T Cells in Attacking Tumors
Enzyme acts as an epigenetic checkpoint of T cell function to treat cancer.
Investigational Keytruda Combination Therapy Explored in Lung Cancer
Drug combination expected to increase efficacy of pembrolizumab (Keytruda) in patients with non-small cell lung cancer.
Novel Keytruda Combination Shows Promise Treating Lung Cancer
Novel pathogen-associated molecular pattern drug combined with checkpoint inhibitor also evaluated in non small cell lung cancer.
Novel Scan May Predict Coronary Artery Disease, Heart Attacks
Imaging technique detects inflammation that precedes cardiovascular disease and heart attacks.
Tomato Consumption Linked to Reduced Risk of Skin Cancer
Mice fed a diet enriched with red tomatoes observed to be less likely to develop skin cancer.
Successful Management of Multiple Sclerosis Starts with Shared Decision-Making
Involving patients in the decision-making process can improve multiple sclerosis treatment adherence and overall quality-of-life.
Pharmacy Week in Review: July 21, 2017
AÂ look at the top stories in pharmacy last week.
Watch
A look at the top stories in pharmacy last week.
Trending News Today: Senate Leaders Continue Push for ACA Repeal
Top news of the day from across the healthcare landscape.
Trending News Today: Affordable Care Act Repeal Faces Hurdles
Tapping Specialty Market Potential Tops SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
Hepatitis C Eliminated Transplanted Infected Kidneys
Transplanting organs from donors infected with hepatitis C found to be a viable option.
FDA Accepts sBLA for Inflammatory Disorder Biologic
Hizentra may treat patients with chronic inflammatory demyelinating polyneuropathy.
NCPA Urges House Committee to Support Three Medicare-Strengthening Bills
Cancer Mortality High in Rural America
Rural areas have a higher rate of death for lung, colorectal, prostate, and cervical cancers.
Generic Ophthalmic Drugs Could Save Millions for Medicare
Eye care providers found to prescribe more branded drugs than any other specialty.
Rural Americans Face Higher Risk of Cancer
Cancer rates in rural America decreasing slower than urban areas.
CDC Awards $12 Million to Combat Opioid Epidemic
New initiative will help fund surveillance technology to control the rate of opioid-related overdoses.
Herpes Virus Targets Metastatic Melanomas in the Brain
Stem cells loaded with oncolytic herpes simplex virus significantly slowed tumor growth in mice.
Diabetes Linked to Changes in Oral Microbiome, Periodontitis
Type 2 diabetes can alter the oral microbiome and lead to inflammation.
FDA Works to Reduce Antibiotic Misuse, Resistance
Antibiotic-resistant bacteria causes millions of infections in the United States each year.
What Role Do Statins Play in Ovarian Cancer Treatment?
Pitavastatin may serve as a potential treatment for drug-resistant ovarian cancer.
Current Treatments Prove Effective Against MRSA Infections
High cure rates for MRSA infections observed with certain antimicrobials.
Novel Approach Can Immobilize Cancer Cells
Attacking overgrown lamellipodia and filopodia could prevent cancer metastasis.
Trending News Today: GOP Leaders Now Seeking to Repeal, Not Replace ACA
Top news of the day from across the health care landscape.
Trending News Today: HIV/AIDS Related Deaths on the Decline
Antiviral Drugs Reduce Liver Cancer Risk in Patients With Hepatitis C
New generation of antiviral drugs cause significant reduction in the risk for the most common type of adult liver cancer in patients with HCV.